Metabolism - Clinical and Experimental
Volume 55, Issue 3 , Pages 300-308, March 2006

α2 Isoform–specific activation of 5′adenosine monophosphate–activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-d-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle

  • Masako Nakano

      Affiliations

    • Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
  • ,
  • Taku Hamada

      Affiliations

    • Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
  • ,
  • Tatsuya Hayashi

      Affiliations

    • Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
    • Kyoto University Graduate School of Human and Environmental Studies, Kyoto 606-8501, Japan
    • Corresponding Author InformationCorresponding author. Kyoto University Graduate School of Human and Environmental Studies, Kyoto 606-8501, Japan. Tel.: +81 75 753 6640; fax: +81 75 753 6640.
  • ,
  • Shin Yonemitsu

      Affiliations

    • Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
  • ,
  • Licht Miyamoto

      Affiliations

    • Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
  • ,
  • Taro Toyoda

      Affiliations

    • Division of Food Science and Biotechnology, Kyoto University Graduate School of Agriculture, Kyoto 606-8502, Japan
  • ,
  • Satsuki Tanaka

      Affiliations

    • Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
  • ,
  • Hiroaki Masuzaki

      Affiliations

    • Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
  • ,
  • Ken Ebihara

      Affiliations

    • Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
  • ,
  • Yoshihiro Ogawa

      Affiliations

    • Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
  • ,
  • Kiminori Hosoda

      Affiliations

    • Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
  • ,
  • Gen Inoue

      Affiliations

    • Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
  • ,
  • Yasunao Yoshimasa

      Affiliations

    • Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
  • ,
  • Akira Otaka

      Affiliations

    • Department of Bioorganic Medicinal Chemistry, Kyoto University Graduate School of Pharmaceutical Sciences, Kyoto 606-8501, Japan
  • ,
  • Toru Fushiki

      Affiliations

    • Division of Food Science and Biotechnology, Kyoto University Graduate School of Agriculture, Kyoto 606-8502, Japan
  • ,
  • Kazuwa Nakao

      Affiliations

    • Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan

Received 27 October 2004; accepted 24 September 2005.

Abstract 

5′Adenosine monophosphate–activated protein kinase (AMPK) has been implicated in exercise-induced stimulation of glucose metabolism in skeletal muscle. Although skeletal muscle expresses both the α1 and α2 isoforms of AMPK, the α2 isoform is activated predominantly in response to moderate-intensity endurance exercise in human and animal muscles. The purpose of this study was to determine whether activation of α2 AMPK plays a role in increasing the rate of glucose transport, promoting glucose transporter 4 (GLUT4) expression, and enhancing insulin sensitivity in skeletal muscle. To selectively activate the α2 isoform, we used 5-aminoimidazole-4-carboxamide-1-β-d-ribonucleoside (AICAR), which is metabolized in muscle cells and preferentially stimulates the α2 isoform. Subcutaneous administration of 250 mg/kg AICAR activated the α2 isoform for 90 minutes, but not the α1 isoform in hind limb muscles of the C57/B6J mouse. The maximal activation of the α2 isoform was observed 30 to 60 minutes after administration of AICAR and was similar to the activation induced by a 30-minute swim in a current pool. The increase in α2 activity paralleled the phosphorylation of Thr172, the essential residue for full kinase activation, and the activity of acetyl-coenzyme A carboxylase β, a known substrate of AMPK in skeletal muscle. Subcutaneous injection of AICAR rapidly increased, by 30%, the rate of 2-deoxyglucose (2DG) transport into soleus muscle; 2DG transport increased within 30 minutes and remained elevated for 4 hours after administration of AICAR. Repeated intraperitoneal injection of AICAR, 3 times a day for 4 to 7 days, increased soleus GLUT4 protein by 30% concomitant with a significant 20% increase in insulin-stimulated 2DG transport. These data suggest that moderate endurance exercise promotes glucose transport, GLUT4 expression, and insulin sensitivity in skeletal muscle at least partially via activation of the α2 isoform of AMPK.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0026-0495(05)00359-8

doi:10.1016/j.metabol.2005.09.003

Metabolism - Clinical and Experimental
Volume 55, Issue 3 , Pages 300-308, March 2006